Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging

S. S. Liau, Michael Camilleri, D. Y. Kim, D. Stephens, D. D. Burton, M. K. O'Connor

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Three-dimensional single-photon emission computed tomography (SPECT) imaging allows noninvasive measurement of human postprandial gastric accommodation. The aim of this study was to determine whether 99mTCO4-SPECT demonstrates effects on pre- and postprandial gastric volumes of intravenous (i.v.) erythromycin lactobionate and sublingual isosorbide dinitrate, as predicted from previous literature. Twenty volunteers received no medication (controls), while 12 were randomized to either i.v. erythromycin 2 mg kg-1 over 20 min, or 10 mg sublingual isosorbide. After a 10-min preprandial SPECT measurement, a standard 300-mL, 300-kcal liquid meal was ingested, followed by a 20-min postprandial measurement. Gastric images were reconstructed from transaxial images and total volume was measured using the Analyse™ software system. Fasting gastric volume was greater with isosorbide [223 ± 14 (SE) mL vs. 174 ± 9 mL, control; P <0.05], and postprandial volume was lower with erythromycin [393 ± 27 mL vs. 582 ± 17 mL, control; P <0.05]. The ratio of postprandial over fasting volume and mean difference between pre- and postprandial volumes were significantly lower in both drug groups compared to controls. We conclude that 99mTCO4-SPECT imaging is able to semiquantitatively demonstrate pharmacological modulation of fasting gastric volume and postprandial accommodation in humans.

Original languageEnglish (US)
Pages (from-to)533-542
Number of pages10
JournalNeurogastroenterology and Motility
Volume13
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Single-Photon Emission-Computed Tomography
Stomach
Pharmacology
Isosorbide
Sodium Pertechnetate Tc 99m
Fasting
Erythromycin
Isosorbide Dinitrate
Meals
Volunteers
Software
Pharmaceutical Preparations

Keywords

  • Accommodation
  • Erythromycin
  • Nitrate
  • SPECT
  • Stomach

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology
  • Neuroscience(all)

Cite this

Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. / Liau, S. S.; Camilleri, Michael; Kim, D. Y.; Stephens, D.; Burton, D. D.; O'Connor, M. K.

In: Neurogastroenterology and Motility, Vol. 13, No. 6, 2001, p. 533-542.

Research output: Contribution to journalArticle

Liau, S. S. ; Camilleri, Michael ; Kim, D. Y. ; Stephens, D. ; Burton, D. D. ; O'Connor, M. K. / Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. In: Neurogastroenterology and Motility. 2001 ; Vol. 13, No. 6. pp. 533-542.
@article{b1963a644ebc4093a81944c35a2b70ce,
title = "Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging",
abstract = "Three-dimensional single-photon emission computed tomography (SPECT) imaging allows noninvasive measurement of human postprandial gastric accommodation. The aim of this study was to determine whether 99mTCO4-SPECT demonstrates effects on pre- and postprandial gastric volumes of intravenous (i.v.) erythromycin lactobionate and sublingual isosorbide dinitrate, as predicted from previous literature. Twenty volunteers received no medication (controls), while 12 were randomized to either i.v. erythromycin 2 mg kg-1 over 20 min, or 10 mg sublingual isosorbide. After a 10-min preprandial SPECT measurement, a standard 300-mL, 300-kcal liquid meal was ingested, followed by a 20-min postprandial measurement. Gastric images were reconstructed from transaxial images and total volume was measured using the Analyse™ software system. Fasting gastric volume was greater with isosorbide [223 ± 14 (SE) mL vs. 174 ± 9 mL, control; P <0.05], and postprandial volume was lower with erythromycin [393 ± 27 mL vs. 582 ± 17 mL, control; P <0.05]. The ratio of postprandial over fasting volume and mean difference between pre- and postprandial volumes were significantly lower in both drug groups compared to controls. We conclude that 99mTCO4-SPECT imaging is able to semiquantitatively demonstrate pharmacological modulation of fasting gastric volume and postprandial accommodation in humans.",
keywords = "Accommodation, Erythromycin, Nitrate, SPECT, Stomach",
author = "Liau, {S. S.} and Michael Camilleri and Kim, {D. Y.} and D. Stephens and Burton, {D. D.} and O'Connor, {M. K.}",
year = "2001",
doi = "10.1046/j.1365-2982.2001.00287.x",
language = "English (US)",
volume = "13",
pages = "533--542",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging

AU - Liau, S. S.

AU - Camilleri, Michael

AU - Kim, D. Y.

AU - Stephens, D.

AU - Burton, D. D.

AU - O'Connor, M. K.

PY - 2001

Y1 - 2001

N2 - Three-dimensional single-photon emission computed tomography (SPECT) imaging allows noninvasive measurement of human postprandial gastric accommodation. The aim of this study was to determine whether 99mTCO4-SPECT demonstrates effects on pre- and postprandial gastric volumes of intravenous (i.v.) erythromycin lactobionate and sublingual isosorbide dinitrate, as predicted from previous literature. Twenty volunteers received no medication (controls), while 12 were randomized to either i.v. erythromycin 2 mg kg-1 over 20 min, or 10 mg sublingual isosorbide. After a 10-min preprandial SPECT measurement, a standard 300-mL, 300-kcal liquid meal was ingested, followed by a 20-min postprandial measurement. Gastric images were reconstructed from transaxial images and total volume was measured using the Analyse™ software system. Fasting gastric volume was greater with isosorbide [223 ± 14 (SE) mL vs. 174 ± 9 mL, control; P <0.05], and postprandial volume was lower with erythromycin [393 ± 27 mL vs. 582 ± 17 mL, control; P <0.05]. The ratio of postprandial over fasting volume and mean difference between pre- and postprandial volumes were significantly lower in both drug groups compared to controls. We conclude that 99mTCO4-SPECT imaging is able to semiquantitatively demonstrate pharmacological modulation of fasting gastric volume and postprandial accommodation in humans.

AB - Three-dimensional single-photon emission computed tomography (SPECT) imaging allows noninvasive measurement of human postprandial gastric accommodation. The aim of this study was to determine whether 99mTCO4-SPECT demonstrates effects on pre- and postprandial gastric volumes of intravenous (i.v.) erythromycin lactobionate and sublingual isosorbide dinitrate, as predicted from previous literature. Twenty volunteers received no medication (controls), while 12 were randomized to either i.v. erythromycin 2 mg kg-1 over 20 min, or 10 mg sublingual isosorbide. After a 10-min preprandial SPECT measurement, a standard 300-mL, 300-kcal liquid meal was ingested, followed by a 20-min postprandial measurement. Gastric images were reconstructed from transaxial images and total volume was measured using the Analyse™ software system. Fasting gastric volume was greater with isosorbide [223 ± 14 (SE) mL vs. 174 ± 9 mL, control; P <0.05], and postprandial volume was lower with erythromycin [393 ± 27 mL vs. 582 ± 17 mL, control; P <0.05]. The ratio of postprandial over fasting volume and mean difference between pre- and postprandial volumes were significantly lower in both drug groups compared to controls. We conclude that 99mTCO4-SPECT imaging is able to semiquantitatively demonstrate pharmacological modulation of fasting gastric volume and postprandial accommodation in humans.

KW - Accommodation

KW - Erythromycin

KW - Nitrate

KW - SPECT

KW - Stomach

UR - http://www.scopus.com/inward/record.url?scp=0035685593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035685593&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2982.2001.00287.x

DO - 10.1046/j.1365-2982.2001.00287.x

M3 - Article

C2 - 11903914

AN - SCOPUS:0035685593

VL - 13

SP - 533

EP - 542

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 6

ER -